日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TNFR1 signaling promotes pancreatic tumor growth by limiting dendritic cell number and function

TNFR1信号通路通过限制树突状细胞的数量和功能来促进胰腺肿瘤的生长。

Muhammad S Alam ,Matthias M Gaida ,Hagen R Witzel ,Shizuka Otsuka ,Aamna Abbasi ,Theresa Guerin ,Abdalla Abdelmaksoud ,Nathan Wong ,Margaret C Cam ,Serguei Kozlov ,Jonathan D Ashwell

Calcineurin is an adaptor required for assembly of the TCR signaling complex

钙调磷酸酶是TCR信号复合物组装所必需的接头蛋白。

Shizuka Otsuka ,Debjani Dutta ,Chuan-Jin Wu ,Muhammad S Alam ,Jonathan D Ashwell

Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels

视神经素缺乏和不足导致小胶质细胞 TDP-43 蛋白水平升高

Nikolina Prtenjaca, Matea Rob, Muhammad S Alam, Andrea Markovinovic, Cristiana Stuani, Emanuele Buratti, Ivana Munitic

Cocirculation of COVID-19 and dengue: A perspective from Pakistan

新冠病毒与登革热的共同传播:来自巴基斯坦的视角

Rana, Muhammad S; Alam, Muhammad M; Ikram, Aamer; Zaidi, Syed S Z; Salman, Muhammad; Khurshid, Adnan

Unique properties of TCR-activated p38 are necessary for NFAT-dependent T-cell activation

TCR激活的p38的独特特性对于NFAT依赖性T细胞活化是必要的

Muhammad S Alam, Matthias M Gaida, Subrata Debnath, Harichandra D Tagad, Lisa M Miller Jenkins, Ettore Appella, M Jubayer Rahman, Jonathan D Ashwell

Proximity Ligation Assay (PLA)

邻位连接试验 (PLA)

Muhammad S Alam

Discovery and Characterization of a Biologically Active Non-ATP-Competitive p38 MAP Kinase Inhibitor

发现并表征具有生物活性的非 ATP 竞争性 p38 MAP 激酶抑制剂

Brice A P Wilson, Muhammad S Alam, Tad Guszczynski, Michal Jakob, Shilpa R Shenoy, Carter A Mitchell, Ekaterina I Goncharova, Jason R Evans, Peter Wipf, Gang Liu, Jonathan D Ashwell, Barry R O'Keefe

Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression

选择性抑制浸润性 T 细胞中的 p38 替代活化途径可抑制胰腺癌进展

Muhammad S Alam, Matthias M Gaida, Frank Bergmann, Felix Lasitschka, Thomas Giese, Nathalia A Giese, Thilo Hackert, Ulf Hinz, S Perwez Hussain, Serguei V Kozlov, Jonathan D Ashwell